What we know of breast cancer drugs may be spin & bias - Dr. Ian Tannock
They are praiseworthy journals in the world of medicine and research: The Lancet, The New England Journal of Medicine and the Journal of Clinical Oncology. But a new study from researchers at the University of Toronto's Princess Margaret Cancer Centre suggests not everything they publish is deserving of praise.
The Canadian study reviewed 164 trials for breast cancer treatment -- and found that researchers frequently "spin" their results to paint them in a more positive light, while underplaying the negative side effects of the drugs they research.
What we know of breast cancer drugs may be spin & bias - Panel
Well, to respond to some of the concerns raised by Dr. Tannock's research, we were joined by Dr. John Fletcher. He is the Editor-in-Chief of the Canadian Medical Association Journal. He was in our Ottawa Studio. And Dr. An Wen Chan is a scientist at Women's College Hospital and Research Institute in Toronto and an Assistant Professor of Medicine at the University of Toronto.
This segment was produced by The Current's Dawna Dingwall.
Other segments from today's show: